July 14, 2023
By Priya Venkatesan The REPRIEVE trial has shown a benefit of statins in reducing the risk of cardiovascular events in people living with HIV, but many […]
May 3, 2023
By Emily Harris People with HIV and a low to moderate traditional risk of cardiovascular disease who took a daily 4-mg dose of pitavastatin reduced their risk […]
April 13, 2023
By Liz Highleyman Large trial finds that pitavastatin lowered the risk for major cardiovascular events by 35%. Read the full article here.
April 13, 2023
By Megan Brooks An international clinical trial testing statin therapy for primary cardiovascular prevention in people living with HIV has been stopped early due to strong […]
April 13, 2023
By Shelley Wood HIV is merely a “risk modifier” in current guidelines; these results pave the way for a new primary-prevention indication for statins. Read the […]
March 16, 2023
By Barbara Jungwirth People living with HIV (PLWH) taking integrase strand transfer inhibitors (INSTIs) gained more weight during the first two years of that regimen than […]
March 13, 2023
Press Release from Massachusetts General Hospital Read the full feature here.
November 14, 2022
In Massachusetts General Hospital Advances in Motion Read the full feature here.
November 14, 2022
In Massachusetts General Hospital Snapshot of Science Read the full newsletter here.
July 14, 2023
By Priya Venkatesan The REPRIEVE trial has shown a benefit of statins in reducing the risk of cardiovascular events in people living with HIV, but many […]
May 3, 2023
By Emily Harris People with HIV and a low to moderate traditional risk of cardiovascular disease who took a daily 4-mg dose of pitavastatin reduced their risk […]
April 13, 2023
By Liz Highleyman Large trial finds that pitavastatin lowered the risk for major cardiovascular events by 35%. Read the full article here.
April 13, 2023
By Megan Brooks An international clinical trial testing statin therapy for primary cardiovascular prevention in people living with HIV has been stopped early due to strong […]
April 13, 2023
By Shelley Wood HIV is merely a “risk modifier” in current guidelines; these results pave the way for a new primary-prevention indication for statins. Read the […]
March 16, 2023
By Barbara Jungwirth People living with HIV (PLWH) taking integrase strand transfer inhibitors (INSTIs) gained more weight during the first two years of that regimen than […]
March 13, 2023
Press Release from Massachusetts General Hospital Read the full feature here.
November 14, 2022
In Massachusetts General Hospital Advances in Motion Read the full feature here.
November 14, 2022
In Massachusetts General Hospital Snapshot of Science Read the full newsletter here.